1. Home
  2. FC vs MDXH Comparison

FC vs MDXH Comparison

Compare FC & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Covey Company

FC

Franklin Covey Company

HOLD

Current Price

$16.83

Market Cap

193.2M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.38

Market Cap

167.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FC
MDXH
Founded
1983
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
167.8M
IPO Year
1992
2021

Fundamental Metrics

Financial Performance
Metric
FC
MDXH
Price
$16.83
$3.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$24.50
$7.67
AVG Volume (30 Days)
124.2K
118.6K
Earning Date
01-07-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$267,067,000.00
$103,069,000.00
Revenue This Year
$2.82
$23.34
Revenue Next Year
$4.35
$22.98
P/E Ratio
$70.70
N/A
Revenue Growth
N/A
21.68
52 Week Low
$14.04
$1.35
52 Week High
$39.22
$5.33

Technical Indicators

Market Signals
Indicator
FC
MDXH
Relative Strength Index (RSI) 53.77 45.52
Support Level $16.63 $3.20
Resistance Level $17.48 $3.58
Average True Range (ATR) 0.47 0.19
MACD 0.02 0.04
Stochastic Oscillator 51.70 58.00

Price Performance

Historical Comparison
FC
MDXH

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: